Recovering false negatives in CRISPR fitness screens with JLOE
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Merve Dede und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Clustered Regularly Interspaced Short Palindromic Repeats, Neoplasms, Gene Knockout Techniques. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIGMS.
Abstract (Originalsprache)
It is widely accepted that pooled library CRISPR knockout screens offer greater sensitivity and specificity than prior technologies in detecting genes whose disruption leads to fitness defects, a critical step in identifying candidate cancer targets. However, the assumption that CRISPR screens are saturating has been largely untested. Through integrated analysis of screen data in cancer cell lines generated by the Cancer Dependency Map, we show that a typical CRISPR screen has a ∼20% false negative rate, in addition to library-specific false negatives. Replicability falls sharply as gene expression decreases, while cancer subtype-specific genes within a tissue show distinct profiles compared to false negatives. Cumulative analyses across tissues improves our understanding of core essential genes and suggest only a small number of lineage-specific essential genes, enriched for transcription factors that define pathways of tissue differentiation. To recover false negatives, we introduce a method, Joint Log Odds of Essentiality (JLOE), which builds on our prior work with BAGEL to selectively rescue the false negatives without an increased false discovery rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID-Profile: Traver Hart
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIGMS
- Schissler Foundation
- CPRIT Scholar in Cancer Research
- Andrew Sabin Family Fellow
- MD Anderson Cancer Center Support
Zitieren
APA
Dede, M., & Hart, T. (2023). Recovering false negatives in CRISPR fitness screens with JLOE. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad046
Vancouver
Dede M, Hart T. Recovering false negatives in CRISPR fitness screens with JLOE. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad046
BibTeX
@article{Dede2023,
author = {Dede, Merve and Hart, Traver},
title = {Recovering false negatives in CRISPR fitness screens with JLOE},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad046}
}
EUVIMED